Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ajowan seed, derived from the annual herb *Trachyspermum ammi* (also known as ajwain or carom), is a traditional botanical medicine and spice native to the eastern Mediterranean and widely cultivated in India, Iran, and the Middle East. The seeds are rich in essential oils, with the phenolic monoterpene thymol serving as the primary active constituent, alongside carvacrol, γ-terpinene, and p-cymene. Pharmacologically, ajowan seed exhibits antispasmodic, bronchodilatory, anti-inflammatory, analgesic, and antimicrobial properties. Its therapeutic effects are primarily mediated through the blockade of voltage-gated L-type calcium channels, positive allosteric modulation of GABAA receptors, and inhibition of cyclooxygenase (COX) enzymes. Clinical trials have investigated ajowan seed extracts and oils for the management of primary dysmenorrhea, nonalcoholic fatty liver disease, neuropathic pain, and pediatric dental injection pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ajowan seed.